India has taken a major step in documenting pediatric oncology outcomes through its first national survivorship program. Notably, this study reveals that childhood cancer survival rates in India have reached a promising 94.5% overall. Furthermore, the initiative shifts the clinical focus from mere survival to long-term quality of life. Consequently, healthcare providers can now move beyond Western data to address the specific needs of Indian survivors. Professionals looking to enhance their skills in managing long-term outcomes in children may benefit from the International Post Graduate Program In Pediatrics.
Methodology Behind Childhood Cancer Survival India Data
Researchers launched the Indian Childhood Cancer Survivorship (C2S) study in 2016. Specifically, the Indian Paediatric Haematology Oncology Group managed the project across 20 national centers. These centers included major hubs like Delhi, Mumbai, Chennai, Kolkata, and Bengaluru. The analysis currently tracks over 5,400 children who completed treatment between 2016 and 2024. Therefore, the data provides a robust baseline for the country. Additionally, the median follow-up period stands at 3.9 years from the initial diagnosis. Interestingly, the survival rate increases to 98.2% two years after treatment completion.
Clinical Outcomes and Late Effects
Leukaemia remains the most frequent diagnosis, representing 41% of the total cases in the cohort. Other common conditions include Hodgkin lymphoma, bone tumours, and retinoblastoma. Most participants received chemotherapy, while one-third required surgical intervention. Furthermore, about 25% of the cohort underwent radiotherapy. Despite high survival rates, Dr. Rachna Seth emphasizes the importance of monitoring late effects. Survivors may face cardiac dysfunction, fertility concerns, and cognitive issues. Addressing the fundamental principles of cancer treatment and follow-up is crucial, aligning with the scope of the Certification Course In Clinical Oncology. Additionally, systematic tracking is essential to identify relapses and second cancers early. Currently, nearly 36 centers contribute data to this expanding national registry. This infrastructure allows clinicians to develop context-specific survivorship guidelines for the Indian population.
Frequently Asked Questions
Q1: What are the primary long-term medical challenges for survivors?
Survivors may encounter various \”late effects\” after completing treatment. These include cardiac dysfunction, fertility concerns, cognitive impairment, and the risk of second cancers. Consequently, doctors recommend systematic long-term follow-up care.
Q2: How does the survival rate change after the initial two years post-treatment?
The study shows a significant improvement in outcomes over time. While the five-year survival rate is 94.5%, it rises to 98.2% once a child survives the first two years after treatment.
References
- 94.5% kids survive after cancer treatment: Study – ETHealthworld
- Seth R, et al. Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016–2024). The Lancet Regional Health – Southeast Asia. 2026;45.
- Indian Paediatric Haematology Oncology Group (InPOG). InPOG-LE-16-01: The Indian Childhood Cancer Survivorship Study.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.